Information about DL Pharma +
My details
*
*
*

DL Pharma + (SRL)

Company information

Status
Active

Enterprise number

BE0755.325.637

VAT liability
Yes
Established
28-09-2020
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from DL Pharma +

2025 2024 2023 2022
Income statement
Profit/Loss € -13,921 -351% € 5,550 17% € 4,727 -51% € 9,670
Gross margin € -12,041 -230% € 9,265 32% € 7,009 -46% € 13,060
Balance sheet
Balance sheet total € 21,233 -42% € 36,725 13% € 32,388 15% € 28,142
Equity € 11,025 -56% € 24,947 29% € 19,397 32% € 14,670
Debts € 10,208 -13% € 11,778 -9% € 12,992 -4% € 13,472

Publications from DL Pharma +

Date Publication
19-12-2025 Registered Office (NL)
30-09-2020 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of DL Pharma +?
The VAT number of DL Pharma + is BE 0755.325.637.
Wat is the PEPPOL ID of DL Pharma +?
The PEPPOL ID of DL Pharma + is 0208:0755325637. Log in or start a free trial to see the full overview.
When was DL Pharma + founded?
DL Pharma + was founded on 28-09-2020.
What is the address of DL Pharma +?
The current registered office of DL Pharma + is located at Boswegel 27, 9870 Zulte.
When was the last time DL Pharma + filed their annual financial statements?
The most recent financial statements of DL Pharma + were filed on 04-11-2025.
How many employees does DL Pharma + have?
There are currently no employees working at DL Pharma + or no workforce information is available.
What is the annual turnover of DL Pharma +?
At the time of its most recent financial statements, DL Pharma + did not publish any turnover figures. DL Pharma + reported a gross margin of -€12,040.74.